Guangdong Biolight Meditech has announced that it will acquire a 20% stake in a minimally-invasive medical device company based in Changzhou.

The acquisition is expected to cost CNY20m ($3.04m).

Kunming Longjin Pharmaceutical, manufacturer of natural botanical and chemical freeze-dried medicines based in China, has agreed to sell its pharmaceutical technology development subsidiary based in Beijing for CNY2m ($0.3m).

Royal Philips has completed the acquisition of PathXL from Queen’s University.

"By acquiring PathXL, Royal Philips will be able to expand its digital pathology solutions portfolio."

By acquiring PathXL, a digital pathology workflow solutions provider, Royal Philips will be able to expand its digital pathology solutions portfolio.

Paramit Corporation has completed the acquisition of Lathrop Engineering, whose design centre in San Jose, California, will be handed over to the former following the transaction.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition allows Paramit to further improve its design and manufacturing capabilities of complex medical and life sciences instruments.